Breast cancer survivor and rocker Sheryl Crow says she conquered cancer in part due to the type of research funded by "FFANY Shoes on Sale." This Fashion Footwear Association of New York shoe sale features thousands of beautiful shoes sold at half the manufacturer's suggested retail price. All net proceeds are donated to the breast cancer cause.

If you love shoes and wish to help further the fight against breast cancer, tune in to QVC for a night of shopping on October 17 from 7:00 - 10:00 PM ET.

Over the past 10 years, "FFANY Shoes On Sale" has raised more than $16 million and sold over 950,000 pairs of shoes to benefit breast cancer research and education programs. Here's to another great year.

Limits are being placed on profits doctors can make on some cancer drugs, causing oncologists to search for new income. Some fear these physicians may resort to prescribing additional treatments for some patients. Not just any treatments, though -- just the ones with the best reimbursements.

Until 2005, Medicare paid a markup of 20 to 100 percent for many cancer drugs. In 2005, Congress changed the reimbursement system to pay physicians just six percent more than the average price for a given treatment. This decrease has made it difficult for small practices to break even on cancer drug purchases because the purchases are not large enough to receive rebates or discounts from drug manufacturers.

According to a recent New York Times article, some oncologists have attempted to increase profits by performing chemotherapy more often, ordering more diagnostic scans, and by putting pressure on patients to make out-of-pocket drug co-payments.

Say it isn't so.

Opera singer Beverly Sills is reportedly at a Manhattan hospital, gravely ill with cancer and with her daughter by her side. This comes from the Associated Press and while those who know her best neither confirm nor deny the news, Sills did cite health and family reasons when she resigned as chairwoman of the Metropolitan Opera two years ago.

Cancer first struck Sills in 1974. She underwent successful surgery and went on to make her Met singing debut in 1975.

Sills, 78, first hit the opera circuit in 1947 in Philadelphia. She had a bit role in Carmen and later became a star with the smaller New York City Opera and was acclaimed for performances in Douglas Moore's The Ballad of Baby Doe, Massenet's Manon, and Handel's Guilio Cesare. Known by the nickname Bubbles -- which some say matches her personality perfectly -- the red-haired diva made many appearances on The Tonight Show and The Muppet Show. She also sang often with her friend Carol Burnett.

High-profile television and newspaper gosspip columnist Claudia Cohen, most recently a regular correspondent covering entertainment for the syndicated talk show Live With Regis and Kelly, died Friday of ovarian cancer. She was 56.

Known for her aggressive pursuit of celebrity news and her public divorce from billionaire businessman Ronald O. Perelman, Cohen first hit the spotlight in the late 1970s as a reporter and editor for Page Six of The New York Post. She went on to write a gossip column titled I, Claudia for The Daily News of New York, report for Live with Regis and Kathie Lee, and dish celebrity dirt for ABC's The Morning Show.

Cohen is survived by her parents, a brother, and a daughter.

There's so much more to life than money. At the same time, the daily grind definitely depends some on this coveted staple. For one man, whose life did depend on money, it could have been everything. But it wasn't.

Think about this:

Wayne Schenk won $1 million in the New York lottery on January 12 after purchasing a $5 scratch-off ticket. His jackpot win came just five weeks after his diagnosis of inoperable lung cancer was delivered. His one wish: to receive a lump sum so he could receive specialized treatment for his advanced disease.

Lottery officials claim they were sympathetic but just couldn't give him a lump sum. The best they could do was issue him $50,000 annual installments for 20 years.

Schenk, 51, only survived for a little more than one year. He died on April 23 at the Veterans Administration Hospital in Syracuse. At the time of his death, he had received just $34,000.

So money isn't everything. But could it have been?

You may not have known it but actor Sean Connery has been fearing cancer for the past two decades.

The Scottish Connery, 76, has been seeing doctors for 20 years so growths in his throat could be monitored. Fearing the worst -- cancer -- Connery wanted to stay on top of things.

Results from a recent medical appointment reveal Connery has been given the all-clear, according to his brother Neil who is also plagued by throat polyps.

Some were concerned about Connery's absence from a New York Tartan Week charity show he was scheduled to host two weeks ago. Apparently, there was nothing to worry about. He was just just getting his check-up, and he later assured fans he is in good health.

"It is something which needs to be followed through," says his brother. "You have to have yearly checks and that is why Sean went to the hospital, just to make sure everything was all right."

Connery's father died of throat cancer at age 69. Connery himself was rushed home from filming in Africa in 1993 due to throat problems. He later received radiotherapy treatment.

It seems screening for lung cancer doesn't save lives and it doesn't prevent advanced disease. But it does lead to potentially unnecessary and harmful treatment.

This isn't the final word on the use of CT scans to screen smokers and former smokers for the disease. But right now, the hope some experts had for the special X-rays to detect tiny lung abnormalities has been diminished by a large study that is still in the works. And until conclusive evidence says the screening is useful, the American Cancer Society will not endorse the test.

While CT screening did increase diagnosis and treatment -- those screened were three times more likely to be diagnosed with lung cancer and 10 times more likely to have lung surgery than predicted -- study co-author Dr. Peter Bach of Memorial Sloan-Kettering Cancer Center in New York says, "We don't see a trace of evidence that a single life was saved, that a single case of advanced cancer was avoided."

And because CT scanning led to more biopsies and surgeries, patients were put at risk for complications such as lung puncture, bleeding, and infection, according to Bach, whose work is published in the Journal of the American Medical Association.

"Getting screened for lung cancer with CT scanning is not only unproven, it's potentially a risky endeavor," he said.

Until an effective screening tool emerges -- possibly still years away -- experts say there is one surefire way to protect yourself from lung cancer. Stop smoking.

The York Mints "Designer Series" tins are the ultimate fashion accessory. Celebrity designers Nicky Hilton and Nicole Miller created two fresh new York Mints designer tins exclusively to benefit the Young Survival Coalition (YSC). The intricately designed tins house the latest mint offering from York, featuring a soft mint center surrounded by a layer of dark chocolate and hard-candy shell.

Hilton's tin features a chic black and white design with a muted floral pattern, capturing the essence of her signature style. Miller's tin has a black and cream intricately designed palette following suit of her Spring 2007 collection.

Each tin features the designers' signature and will retail for $25 with 100% of the proceeds benefiting the YSC.

The Colorectal Cancer Coalition will visit the New York Stock Exchange tomorrow -- Monday, March 5, 2007 -- and will ring in the start of the business day.

Executive director Carlea Bauman will ring the NYSE Opening Bell in honor of Colorectal Cancer Awareness Month, and you don't have to be in New York to witness the wonder of it all. Just click here and follow instructions for viewing a live webcast of The Opening Bell. It all begins at 9:25 AM Eastern Standard Time. You can also tune it to CNBC for coverage of the event.

The Colorectal Cancer Coalition, also known as C3 and headquartered in Washington DC, pushes for research to improve screening, diagnosis, and treatment of colorectal cancer; for policy decisions that make the most effective colon and rectal cancer prevention and treatment available to all; and for increased awareness that colorectal cancer is preventable, treatable, and beatable.

Hank Bauer, wounded World War II Marine and New York Yankees legacy, died on February 9 at the age of 84. The cause of death -- cancer.

Bauer, who managed the 1966 Baltimore Orioles to their first World Series title, was a three-time All-Star Yankees outfielder during his time with the team that won nine American League pennants and seven World Series titles in just 10 years. Bauer, a Yankees fixture from 1948-59, set the Series record with a 17-game hitting streak. His record still stands.

Yankees owner George Steinbrenner says, "Hank Bauer is an emblem of a generation that helped shape the landscape of our country. He was a natural leader and a teammate in every sense of the word, and his contributions went well beyond the baseball field. His service to the Yankees, his country, and his family shows why I have been so privileged to call him a friend."

Bauer's baseball accomplishments, which also include playing two seasons with and later managing the Kansas City Athletics and scouting for the Yankees and Royals, are not his only claims to fame. He also earned two Bronze Stars and two Purple Hearts for his courageous dedication to the United States.

Enlisting in the Marines shortly after Pearl Harbor, Bauer was wounded in Okinawa when he was hit in the leg by shrapnel just 53 days after he arrived on the island with 64 other men. "Only six of us came out," said Bauer who signed with the Yankees minor league after his discharge and sported his Marine Corps crewcut throughout the baseball career that landed him with the likes of Mickey Mantle, Yogi Berra, and a young Roger Maris.

During the same week Bauer lost his life, two other players of his time also passed away -- Steve Barber, who pitched for Bauer in Baltimore and Lew Burdette, who played against the Yankees in the 1957 and 1958 World Series.

Bauer is remembered by many.

"I am truly heartbroken," says Berra. "Hank was a wonderful teammate and friend for so long. Nobody was more dedicated and proud to be a Yankee, he gave you everything he had."

When she asked her teenage daughters whether or not she should accept the American Cancer Society's Mother of the Year award, the response was a resounding, "Mom, of course." So Sarah Ferguson, the Duchess of York, accepted the anti-cancer honor this week and told ABC's George Stephanopolous on Sunday why she is a good mom and a healthy role model.

"They see that I go running, I get on my bicycle, I do yoga, pilates, whatever else I do," Ferguson said. "Do you know what they do? Get up off the sofa, turn the television off, walk to work, walk around the block, more vegetables, more fruits at school, less soda pops, less fast food."

Ferguson, 47, says cancer prevention starts with good role modeling -- which is exactly what she has done as mom to princesses Beatrice and Eugenie.

"I can safely say one of the best things I've done is be a good mother," Ferguson said.

Ferguson, author of memoir My Story and spokeswoman for Weight Watchers, first became known as the wife of Britain's Prince Andrew, the Duke of York. The pair divorced in 1996, but Ferguson's positive public persona has remained untarnished.

Katherine Schaefer was investigating methods for treating the inflammation seen in Crohn's disease and ulcerative colitis when something terrible happened -- she noticed her carefully cultured cells were dead. And then something wonderful happened -- she realized she had stumbled upon a potential new method of attacking cancerous tumors that have become resistant to existing drugs.

Schaefer and her colleagues at the University of Rochester Medical Center in New York were testing a compound called a PPAR-gamma modulator -- a compound never considered a cancer drug, or a drug of any kind really -- when Schaefer made a calculation error and used a lot more of the compound than she should have. And her cells died.

Upon further study, Schaefer found the compound killed just about every possible epithelial tumor cell. These cells line organs such as the colon and also the skin. The compound, that works like taxane drugs but without eventual tumor resistance, also killed colon tumors in mice without making them sick.

The research team, whose findings are published in the journal International Cancer Research, plans more safety tests in mice. And eventually, if their outcomes are promising, they plan to design something they can patent as a new drug -- because they would love to see this disastrous lab experiment one day lead to treatment for cancers of the colon, esophagus, liver, and skin.

This year alone, 215,000 women will be diagnosed with breast cancer. And sadly, not all of them will be treated equally.

Researchers reported last Tuesday that breast cancer patients who are either obese or poor are more likely to receive lower doses of chemotherapy. This might be why some women relapse and others do not, according to the researchers whose findings appear in the Journal of Clinical Oncology.

This treatment discrepancy seems to stem from doctors who mean well and want to save certain women from severe side effects of chemotherapy. Doctors may be under-dosing obese patients, for example, because a larger dose based on weight could lead to worse side effects. There is no evidence this is true, however.

As for socioeconomic status, researchers report doctors are assuming less-educated patients won't stick with a tough course of treatment -- and so they prescribe less, in hopes patients will complete the regimen.

Researchers found that severely obese women were four times more likely to get less chemotherapy than they need. Women with less than a high school education were three times more likely to receive low doses of chemotherapy. And women living in the South were almost six times more likely to come up short on the drugs they need to save their lives.

"We have new therapies and cures out there for many forms of cancer and sadly, sometimes we're not curing people because they are not getting the full doses that should be standard," says Dr. Gary Lyman who led the study at the University of Rochester Medical Center in New York.

Nearly a decade ago, women in Long Island began to worry about their high rates of breast cancer. So they advocated and lobbied and pushed until a public law was passed that allowed for the creation of the Long Island Breast Cancer Project. Funded by both the National Cancer Institute and the National Institute of Environmental Health Sciences, great data has emerged from this project -- like the data linking breast cancer and household pesticides.

Although much research has linked cancer with pesticides in work and industrial settings, few studies have investigated what these chemicals can do in households -- until now, thanks to research conducted as part of The Long Island Breast Cancer Project.

Published online in the December 13 American Journal of Epidemiology, researchers found an association between lifetime residential pesticide use and breast cancer risk in a sample of 1,508 Long Island women diagnosed with breast cancer between 1996 and 1997. These women were compared to 1,556 random controls. All women were asked to self-report their pesticide exposure and to offer blood samples for the study of organochlorine compound levels -- found in lawn and garden products.

As expected, researchers found an increased breast cancer risk for women whose blood samples showed the highest levels of organochlorine compounds. They also found it hard to find women who did not use lawn and garden pesticides to some degree.

Use of household pesticides has infiltrated our society, says researcher Susan Teitelbaum, assistant professor in the department of community medicine at Mount Sinai School of Medicine in New York, who reports she is happy to see a movement toward use of alternative methods, like integrated pest management.

Teitelbaum has just one recommendation as result of this study. It's quite simple really -- stop using pesticides.

Michael Brecker, Grammy Award-winning jazz saxophonist who performed with the likes of Joni Mitchell and Herbie Hancock, died Saturday of cancer. He was 57.

Brecker, considered one of the most influential saxophonists of the past 25 years, died at a hospital in New York City as a result of myelodysplastic syndrome -- a form of cancer in which the bone marrow stops making healthy blood cells.

The Philadelphia native, who began his solo career in 1987 with a self-titled debut recording that turned into Jazz Album of the Year, was forced by his illness to stop playing music at times. So he channeled his creative efforts into raising awareness of a very important cause -- bone marrow donation.

Brecker is survived by his wife, Susan; his children, Jessica and Sam; a brother and a sister.